These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9384641)

  • 1. Checking adequacy of the semiparametric location shift model with censored data.
    Rossini AJ; Wei LJ; Ying Z
    Lifetime Data Anal; 1996; 2(2):145-57. PubMed ID: 9384641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Censored partial regression.
    Orbe J; Ferreira E; Núñez-Antón V
    Biostatistics; 2003 Jan; 4(1):109-21. PubMed ID: 12925333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frailty models for arbitrarily censored and truncated data.
    Huber-Carol C; Vonta I
    Lifetime Data Anal; 2004 Dec; 10(4):369-88. PubMed ID: 15690991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Checking the censored two-sample accelerated life model using integrated cumulative hazard difference.
    Lee SH; Yang S
    Lifetime Data Anal; 2007 Sep; 13(3):371-80. PubMed ID: 17530398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-consistency estimation of distributions based on truncated and doubly censored survival data with applications to AIDS cohort studies.
    Sun J
    Lifetime Data Anal; 1997; 3(4):305-13. PubMed ID: 9503878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Checking the linear transformation model for clustered failure time observations.
    Hattori S
    Lifetime Data Anal; 2008 Sep; 14(3):253-66. PubMed ID: 18240021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for conducting sensitivity analysis of trials with potentially nonignorable competing causes of censoring.
    Rotnitzky A; Scharfstein D; Su TL; Robins J
    Biometrics; 2001 Mar; 57(1):103-13. PubMed ID: 11252584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AIDS. Combination therapy is more favorable].
    Fortschr Med; 1988 Sep; 106(28):57. PubMed ID: 3069665
    [No Abstract]   [Full Text] [Related]  

  • 10. Zidovudine in early HIV disease.
    McLeod GX
    Hosp Pract (Off Ed); 1993 Mar; 28(3A):9-10. PubMed ID: 8450007
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of CMV retinitis.
    Cox SW; Wahren B
    N Engl J Med; 1992 Jun; 326(25):1701-2; author reply 1702-3. PubMed ID: 1534145
    [No Abstract]   [Full Text] [Related]  

  • 12. Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals.
    Li J; Scheike TH; Zhang MJ
    Lifetime Data Anal; 2015 Apr; 21(2):197-217. PubMed ID: 25421251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonparametric models and methods for designs with dependent censored data: part I.
    O'Gorman JT; Akritas MG
    Biometrics; 2001 Mar; 57(1):88-95. PubMed ID: 11252623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semiparametric probit model for case 2 interval-censored failure time data.
    Lin X; Wang L
    Stat Med; 2010 Apr; 29(9):972-81. PubMed ID: 20069532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of combination antiretroviral therapy for AIDS. An introduction.
    Groopman JE
    Am J Med; 1991 Apr; 90(4A):1S. PubMed ID: 2018044
    [No Abstract]   [Full Text] [Related]  

  • 16. Semiparametric varying-coefficient model for interval censored data with a cured proportion.
    Shao F; Li J; Ma S; Lee ML
    Stat Med; 2014 May; 33(10):1700-12. PubMed ID: 24302535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparametric inference in factorial designs with censored data.
    Akritas MG; LaValley MP
    Biometrics; 1996 Sep; 52(3):913-24. PubMed ID: 8805761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of AIDS with combinations of antiretroviral agents: a summary.
    Groopman JE
    Am J Med; 1991 Apr; 90(4A):27S-30S. PubMed ID: 2018049
    [No Abstract]   [Full Text] [Related]  

  • 19. Semiparametric estimation in a three-state duration-dependent Markov model from interval-censored observations with application to AIDS data.
    Frydman H
    Biometrics; 1995 Jun; 51(2):502-11. PubMed ID: 7662839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rank invariant tests for interval censored data under the grouped continuous model.
    Fay MP
    Biometrics; 1996 Sep; 52(3):811-22. PubMed ID: 8805758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.